We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cardiomyopathy Linked to Faulty Regulation of Heart Protein Succinylation

By LabMedica International staff writers
Posted on 28 Apr 2016
Image: A model of the structure of the SIRT5 protein (Photo courtesy of Wikimedia Commons).
Image: A model of the structure of the SIRT5 protein (Photo courtesy of Wikimedia Commons).
The enzyme SIRT5, also known as sirtuin (silent mating type information regulation 2 homolog) 5, was found to play a critical role in maintaining healthy cardiac function by regulating the lysine succinylation modification of heart cell proteins.

Lysine succinylation is a recently discovered protein posttranslational modification (PTM), and SIRT5 is an efficient desuccinylase enzyme. Although many mammalian proteins have been found to be regulated by lysine succinylation and SIRT5, the physiological significance of succinylation and SIRT5 remains unknown.

To better understand the consequences of protein succinylation, investigators at Cornell University (Ithaca, NY, USA) and their colleagues at Ecole Polytechnique Fédérale de Lausanne (Switzerland) profiled acyl-CoA molecules in various mouse tissues. They discovered that different tissues had different acyl-CoA profiles and that succinyl-CoA was the most abundant acyl-CoA molecule in the heart. This observation prompted them to examine protein lysine succinylation in different mouse tissues in the presence and absence of SIRT5.

The investigators reported in the April 5, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that protein lysine succinylation predominantly accumulated in the heart in mice that had been genetically engineered to lack the gene for Sirt5. Using proteomic studies, they were able to identify many cardiac proteins regulated by SIRT5.

In particular, they found that ECHA (also known as HADHA or hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit), a protein involved in fatty acid oxidation, was a major enzyme that was regulated by SIRT5 and affected heart function. Sirt5 knockout (KO) mice had lower ECHA activity, increased long-chain acyl-CoAs, and decreased ATP in the heart under fasting conditions. On the physiological level, it was found that Sirt5 KO mice developed hypertrophic cardiomyopathy, as evident from the increased heart weight relative to body weight in these animals.

"Our research suggests that perhaps one way to improve heart function is to find a way to improve SIRT5 activity," said senior author Dr. Hening Lin, professor of chemistry and chemical biology at Cornell University.

"The identification of this new role of SIRT5 in cardiomyopathy assigns an important role of this druggable enzyme in one of the major cardiac diseases," said contributing author Dr. Johan Auwerx, professor of energy metabolism at the Ecole Polytechnique Fédérale de Lausanne. "It can be expected that pharmacological interference with these pathways will lead to new therapies for cardiomyopathy that, as such, can extend healthy life span."

Related Links:
Cornell University
Ecole Polytechnique Fédérale de Lausanne
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Rapid Test Reader
DIA5000

DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
PURITAN MEDICAL